22nd Century Group (Nasdaq: XXII) has acquired GVB Biopharma. Read the press release here

  • Home
  • About Us
    • Our Company
    • Our Leadership Team
    • Board of Directors
  • Reduced Nicotine Tobacco
    • VLN®
    • Clinical Studies & Commentaries
  • Hemp/Cannabis Innovation
    • GVB Biopharma
  • Hops Research
  • News
  • Investors
    • Overview
    • New Investor / Latest Resources
    • Events
    • News
    • Stock Data
    • SEC Filings
    • Analyst Coverage
    • Corporate Governance
    • Annual Reports
    • FAQs
  • Contact Us

Press Releases

Investors

Investors

  • Overview
  • New Investor / Latest Resources
  • Events
  • News
    • Press Releases
  • Stock Data
    • Quote
    • Charts
    • Historical Data
    • Trades
  • SEC Filings
  • Analyst Coverage
  • Corporate Governance
  • Annual Reports
  • FAQs
  • News

  • Press Releases
Aug 03, 2015 12:49pm EDT

22nd Century Group to File Second Quarter 2015 Financial Results And Announces Conference Call to Provide Business Update

Jun 17, 2015 10:58am EDT

Phase II Clinical Trial Featuring 22nd Century’s Very Low Nicotine Tobacco Accepted for Publication

Jun 15, 2015 11:15am EDT

22nd Century Group Obtains Cigarette Distribution Licenses in New York State

Jun 02, 2015 4:59pm EDT

22nd Century Group Announces Closing of $6 Million Registered Direct Offering

May 29, 2015 7:30am EDT

22nd Century Group Announces $6 Million Registered Direct Offering

May 28, 2015 10:35am EDT

22nd Century Announces Launch of “0.0 mg Nicotine” MAGIC Cigarettes in the United Kingdom

May 26, 2015 12:18pm EDT

22nd Century Launches Powerful Consumer Marketing Initiative

May 22, 2015 1:46pm EDT

22nd Century Group Appoints Nora B. Sullivan to Board of Directors

May 21, 2015 12:46pm EDT

22nd Century Group Signs Contract with Rich & Rhine

May 20, 2015 5:14pm EDT

22nd Century Group to Present at Investor Conferences

RSS
  • Prev
    • 1...
    • 25
    • 26
    • 27
    • 28
    • 29
    • 30
    • 31
    • 32
    • 33
    • 34
    • ...38
    Next
    • Email Alerts
    • Contact
    • RSS News Feed
    © 2023 22nd Century Group, Inc. All Rights Reserved.
    Privacy Policy / CCPA Disclaimer Sitemap